AssessmentExecutive Assessment
 
       
Executive Team
 

Iyabode Akinsanya-Beysolow,
MD, MPH


Paul G. Auwaerter,
MD, MBA, FACP, FIDSA

John G. Bartlett,
MD

Todd T. Brown,
MD, Phd


Michael A. Chattergoon,
MD, PhD


Joseph Cofrancesco Jr.,
MD, MPH, FACP


Calvin J. Cohen,
MD, MSc


Sara E. Cosgrove,
MD, MS


Joel E. Gallant,
MD, MPH


Amita Gupta,
MD, MHS


Lawrence Herman,
MPA, RPA-C, DFAAPA


Charles Hicks,
MD


Christopher Hoffmann,
MD, MPH


Rebecca A. Kazin,
MD


Gregory M. Lucas,
MD, PhD


Kieren A. Marr,
MD


Michael Melia,
MD


Dionissios Neofytos,
MD, MPH


Eric Nuermberger,
MD


Kathleen R. Page,
MD


Trish M. Perl,
MD, MSc


Paul A. Pham,
PharmD


Richard E. Rothman,
MD, PhD, FACEP


Paul E. Sax,
MD


Mark S. Sulkowski,
MD


Aimee K. Zaas,
MD, MHS





 

Title: "Highlights from the 19th Conference on Retroviruses and Opportunistic Infections: CROI in Context”

Presented by: The Johns Hopkins University School of Medicine

Release Date: May 15, 2012
Expiration Date: May 15, 2013

Estimated time to complete this activity is 60 minutes.
There are no prerequisites.

Acknowledgement of Commercial Support: Supported by an educational grant from Abbott Laboratories

 

Executive Team
“New Strategies for the Diagnosis and Treatment of Clostridium difficile Infection”
This activity has been approved for 1.25 AMA PRA Category 1 Credit™.

“Highlights from the 19th Conference on Retroviruses and Opportunistic Infections:
CROI in Context”
This activity has been approved for 1.0 AMA PRA Category 1 Credit™.

“Meeting the Challenge of Fungal Infection: Risk Assessment and the Role of Antifungal Agents”
This activity has been approved for 1.50 AMA PRA Category 1 Credit™

“Identification and Treatment of Community-Associated MRSA”
This activity has been approved for 0.75 AMA PRA Category 1 Credit™